Provided by Tiger Trade Technology Pte. Ltd.

Sanara MedTech Inc.

34.38
-0.0700-0.20%
Volume:460.12K
Turnover:15.79M
Market Cap:315.16M
PE:-9.33
High:34.50
Open:34.50
Low:34.26
Close:34.45
52wk High:35.95
52wk Low:16.05
Shares:9.17M
Float Shares:3.76M
Volume Ratio:1.47
T/O Rate:12.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6860
EPS(LYR):-4.3611
ROE:-1.32%
ROA:7.64%
PB:39.68
PE(LYR):-7.88

Loading ...

Switzerland's Kuros Biosciences Swing to H1 Profit as Revenue Jumps

Reuters
·
Aug 13

Sanara Medtech Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Sanara MedTech Q2 EPS $(0.05) Misses $0.02 Estimate, Sales $28.137M Miss $28.950M Estimate

Benzinga Earnings
·
Aug 12

Sanara MedTech Berbalik Rugi GAAP Jadi USD 0,4 Juta Pada Q2 FY26; Revenue Naik 9% Jadi USD 28,1 Juta

Reuters
·
Aug 12

Sanara MedTech Q2 Revenue Rises on Soft-Tissue Product Growth

Reuters
·
Aug 12

Sanara MedTech Koreksi Biaya Terminasi Merger; Ubah Jadi USD 9,66 Juta Dari USD 22,54 Juta

Reuters
·
Aug 12

Sanara Medtech Inc Expected to Post a Loss of 2 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Sanara MedTech downgraded to Hold from Buy at Freedom Broker

TIPRANKS
·
Aug 03

Vericel Beats Q2 Revenue Estimates, Boosts Annual Outlook

Reuters
·
Jul 30

Sanara MedTech Cut to Neutral from Buy by HC Wainwright & Co.

Dow Jones
·
Jul 30

HC Wainwright Downgrades Sanara MedTech to Neutral From Buy, Adjusts PT to $35 From $36

MT Newswires Live
·
Jul 30

Sanara Medtech Inc. : H.c. Wainwright Cuts to Neutral from Buy

THOMSON REUTERS
·
Jul 30

Mimedx to Acquire Sanara Medtech

Reuters
·
Jul 30

MiMedx Q2 Sales Fall Less than Expected; Set to Acquire Sanara MedTech

Reuters
·
Jul 30

MiMedx to Buy Sanara MedTech in Cash-and-stock Deal Valued at USD 35 a Share

Reuters
·
Jul 30

MiMedx to Acquire Sanara Medtech

THOMSON REUTERS
·
Jul 30

Sanara Medtech - MiMedx to Finance Deal with Cash on Hand and $300 Mln Term Loan from Hayfin

THOMSON REUTERS
·
Jul 30

Sanara Medtech Inc: Deal Immediately Accretive to Revenue Growth, Gross Margin and Adjusted Ebitda Margin

THOMSON REUTERS
·
Jul 30

Sanara Medtech - Combined 2027 Revenue Expected to Exceed $400 Mln, Adj Ebitda Margin over 20%

THOMSON REUTERS
·
Jul 30

Sanara Medtech - Anticipates over $20 Mln in Run-Rate Cost Synergies

THOMSON REUTERS
·
Jul 30